
Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Photocure
Market Cap: NOK 1.4b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 52.10
7D
8.3%
1Y
-14.7%
Nykode Therapeutics
Market Cap: NOK 1.1b
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 3.29
7D
-2.7%
1Y
95.8%
Lytix Biopharma
Market Cap: NOK 622.9m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 8.10
7D
-3.8%
1Y
-14.4%